Navigation Links
Diagnoplex Closes CHF10 Million ($8.3 Million) Series A Financing
Date:12/10/2008

s obtained in a training set of 140 patients have shown that the power of the molecular platform allows Colox to detect even the pre-cancerous stage of adenoma. Early detection and intervention by colonoscopy can have an important impact on the epidemiology of colon cancer, one of the main causes of cancer related mortality in the western world. It is estimated that survival rates improve to 90% when colorectal cancer is detected early.

"We are excited to be working with Diagnoplex on developing their technology for the non-invasive detection of colon cancer. Colon cancer is one of the leading causes of death and early detection makes a huge difference in patient survival. Since compliance with guidelines for screening with colonoscopy is poor, too many cases are detected too late. The need for non-invasive screening is tremendous," said Anja König.

"Diagnoplex is targeting a very exciting market opportunity for molecular diagnostics. With the rise of personalized medicine, this is one of the healthcare areas with vast market potential that is currently underserved. We believe that Diagnoplex will be a leader in this important field," said Thomas Goebel.

"We are excited to welcome a high quality group of investors and look forward to working with this outstanding syndicate to bring powerful new cancer screening approaches to bear on the early detection of cancer," said Stavros Therianos, Ph.D., chief executive officer and founder of Diagnoplex.

About Novartis Venture Fund

Novartis Venture Fund, established in 1996, has currently over $650 million under management and is invested in more than 50 private companies. The Novartis Venture Fund invests in companies which have the potential to lead the next innovation wave in core therapeutic fields or explore new business areas that will be critical to patient care. The NVF team of eight investment professionals located in Basel,
'/>"/>

SOURCE Diagnoplex
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. OncoVista, Inc. Closes on $6.8 Million Financing and Acquires Control of a Public Shell Company
2. Genmab Discloses Target and Development Plans for HuMax-Inflam
3. Oxford Finance Corporation Closes $7 Million Debt Facility with Othera Pharmaceuticals
4. RoundTable Healthcare Partners Closes Sale of MedAssist Holding, Inc. to Firstsource Solutions Limited
5. Gilde Healthcare Partners Closes EUR 150 Million European Healthcare Venture Fund
6. Symmetry Medical Discloses Accounting Issues at Sheffield, UK Operating Unit and Possible Restatement
7. BioVex Closes Second Round of Series E Financing
8. Pharmaxis Closes Share Purchase Plan
9. The closest look ever at native human tissue
10. Helix BioPharma closes $16.9 million private placement of common shares
11. Senesco Technologies Closes on Additional $4.0 Million of Previously Announced Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... 2015 Research and ... of the "Analysis of the Global Flow ... Globally, flow cytometry remains a popular ... cancer, and stem cells. But the market is ... of demand from underdeveloped nations to quantitate CD4 ...
(Date:7/28/2015)... YORK , July 28, 2015 Tauriga ... a diversified life sciences company, today announced that its ... shares of common stock of the Company from 1,000,000,000 ... on July 27, 2015 at the Law Offices of ...  At the Special Meeting, there were 480,655,929 shares of ...
(Date:7/28/2015)... , July 28, 2015 CSL Behring ... Administration has accepted for review the company,s Biologics License ... single-chain (rVIII-SingleChain) for the treatment of hemophilia A. In ... Hemophilia A is a ... VIII; nearly all affected patients are male. People with ...
(Date:7/28/2015)...  Faced with increasing challenges such as costly ... symptomatic, the global healthcare industry today is gradually ... curing or significantly changing the course of a ... regenerative medicine as a viable alternative. ... health with the potential to resolve unmet medical ...
Breaking Biology Technology:Analysis of the Global Flow Cytometry Market 2012-2018 with a 2014 Base Year and a 2015-2018 Forecast Period 2Tauriga Sciences, Inc. Stockholders Approve Increase In Authorized Common Stock 2Tauriga Sciences, Inc. Stockholders Approve Increase In Authorized Common Stock 3U.S. FDA Accepts for Review CSL Behring's Biologics License Application for Its Novel rVIII-SingleChain Therapy for Patients with Hemophilia A 2U.S. FDA Accepts for Review CSL Behring's Biologics License Application for Its Novel rVIII-SingleChain Therapy for Patients with Hemophilia A 3Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 2Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 3Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 4Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 5
... Coley,Pharmaceutical Group, Inc. (Nasdaq: COLY ), ... Chief Executive Officer, will be presenting a,corporate update ... Conference at 10:00am ET on November 27th, 2007 ... may access an audio webcast of the presentation ...
... International,(Nasdaq: PRAI ), a leading clinical research ... named its senior vice president of human,resources., ... that will,help PRA grow," said Chief Executive Officer, ... in addition to strong tactical and,strategic skills in ...
... ACUSON S2000 Ultrasound System Dramatically Enhances the Way Ultrasound, Departments ... ... Applications, CHICAGO, Nov. 26 ... of North America (RSNA) from,Nov. 25 to 30 at McCormick Place ...
Cached Biology Technology:Coley Pharmaceutical Group to Present at the Lazard Capital Markets Fourth Annual Healthcare Conference 2Chambers Joins PRA International as Senior Vice President of Human Resources 2Siemens' New S Class Revolutionizes the Paradigm of Ultrasound Workflow Today and Tomorrow 2Siemens' New S Class Revolutionizes the Paradigm of Ultrasound Workflow Today and Tomorrow 3Siemens' New S Class Revolutionizes the Paradigm of Ultrasound Workflow Today and Tomorrow 4Siemens' New S Class Revolutionizes the Paradigm of Ultrasound Workflow Today and Tomorrow 5Siemens' New S Class Revolutionizes the Paradigm of Ultrasound Workflow Today and Tomorrow 6
(Date:7/8/2015)... NEW YORK , July 8, 2015 ... today announced BD & Guidepoint Mentor, ... free access to Guidepoint,s expert network services. ... developing cutting-edge technologies to improve healthcare delivery and outcomes ... manager, each start-up entrepreneur will be able to directly ...
(Date:7/7/2015)... July 7, 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ... growing mobile commerce market announces a revised version of one of ... commercial will air on CNBC in New York ... and San Francisco metro areas.    ... on Wocket,s ability to replace all the cards in your wallet ...
(Date:6/30/2015)... June 30, 2015 Genisphere announced ... CEO to help further develop Genisphere,s therapeutics capabilities and ... experience, having spent much of the last 25 years ... Baxter Bioscience, and Johnson & Johnson. Tom started his ... and Biotech Corporate Finance. He graduated from Dartmouth College ...
Breaking Biology News(10 mins):BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 2BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 3Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 2Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 3Genisphere Appoints New CEO, Thomas Bliss 2Genisphere Appoints New CEO, Thomas Bliss 3
... interactive tool developed by researchers from the USDA Forest ... energy facility operators make informed decisions on efficient ways ... of migratory bats at wind energy facilities have become ... and the relationship between fatalities at wind energy facilities ...
... The discovery of a gene that causes a form of ... insight into what causes axons, the stems of our nerve ... In the Journal of Clinical Investigation today, an ... the University of Cambridge, and Dr Stephan Zuchner from the ...
... Iowa have worked out the exact function of an enzyme ... in several muscular dystrophies. The findings, which were published Jan. ... to develop rapid, large-scale testing of potential muscular dystrophy therapies. ... onto an important membrane protein called dystroglycan. This sugar chain ...
Cached Biology News:New research helps predict bat presence at wind energy facilities 2Spasticity gene finding provides clues to causes of nerve cell degeneration 2Study reveals enzyme function, could help find muscular dystrophy therapies 2Study reveals enzyme function, could help find muscular dystrophy therapies 3
The FlowTACS Apoptosis Detection Kit is designed specifically for in situdetection of apoptotic...
RayBio Human Cytokine Antibody Array 1.1 (4 array membranes) with Accessory, detects 20 cytokines (for lysate) Class: Antibody Array Products Product Group: Antibody Array...
HybriWell™ hybridization sealing system, 22 mm x 22 mm chamber, 0.15 mm deep *set of 100*...
RABBIT ANTI ISOCITRATE DEHYDROGENASE...
Biology Products: